Noteworthy, in spite of a relatively high daily gluten intake no patients developed positive serum IgA anti-tTG2 and none of those with follow-up biopsies developed atrophy, which are criteria previously used to consider CoD in these patients [25]. Here, CD79A is linked to Atrophy.